Cargando…
Magnesium sulphate therapy in eclampsia: the Sokoto (ultra short) regimen
BACKGROUND: Continuing the administration of magnesium sulphate for 24 hours after the last fit in patients with eclampsia is at best empirical. The challenge of such a regimen is enormous in low-resource countries. The objective of this study was to assess the effectiveness of an ultra-short regime...
Autores principales: | Ekele, Bissallah A, Muhammed, Danjuma, Bello, Lawal N, Namadina, Ibrahim M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2732634/ https://www.ncbi.nlm.nih.gov/pubmed/19691837 http://dx.doi.org/10.1186/1756-0500-2-165 |
Ejemplares similares
-
Treatment of Eclampsia with Magnesium Sulphate
por: Quddus, M. A.
Publicado: (1946) -
Clinical pharmacokinetic properties of magnesium sulphate in women with pre‐eclampsia and eclampsia
por: Okusanya, BO, et al.
Publicado: (2015) -
Eclampsia Treated with Intravenous Injection of Magnesium Sulphate Solution
por: Roy, S. K.
Publicado: (1941) -
Factors influencing the use of magnesium sulphate in pre-eclampsia/eclampsia management in health facilities in Northern Nigeria: a mixed methods study
por: Oguntunde, Olugbenga, et al.
Publicado: (2015) -
A Short Account of Ten Cases of Eclampsia Treated by Intravenous Injections of Magnesium Sulphate
por: Nolan, M. M.
Publicado: (1935)